Ireland is the latest country impacted by the rise in high-potency MDMA in the European market, with the HSE issuing a statement confirming that small pills can inflict significant damage when taken. Prof Eamon Keenan, HSE national clinical lead for addiction services, outlines the risks and symptoms of usage with Anton.
HSE issues warning over high-strength MDMA
Ireland is the latest country impacted by the rise in high-potency MDMA in the European market, w...
09.30 13 Dec 2025
